Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : GILD crawled time : 14:00 save search
Gilead Sets Sights on Hepatitis C Elimination As It Marks 10 Years of Curative Therapies
Published: 2024-02-13 (Crawled : 14:00) - biospace.com/
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.32%
H: 0.11%
C: -1.55%
hepatitis
Gilead Provides Update on Phase 3 EVOKE-01 Study
Published: 2024-01-22 (Crawled : 14:00) - biospace.com/
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -7.78%
H: 0.31%
C: -2.57%
evoke-01 update study
Gilead and Kite Oncology Present Data Demonstrating Car T-cell Therapy Survival Benefit and Showcasing Latest Advances in Blood Cancer Portfolio at ASH 2023
Published: 2023-11-02 (Crawled : 14:00) - biospace.com/
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.47%
H: 1.88%
C: 1.78%
t-cell cancer blood therapy
FDA Approves Veklury® (Remdesivir) for COVID-19 Treatment in Patients With Severe Renal Impairment, Including Those on Dialysis
Published: 2023-07-14 (Crawled : 14:00) - biospace.com/
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.13%
H: 1.34%
C: 0.76%
covid-19 veklury fda renal treatment dialysis
Gilead Receives CHMP Positive Opinion for Trodelvy® in Pre-Treated HR+/HER2- Metastatic Breast Cancer
Published: 2023-06-23 (Crawled : 14:00) - biospace.com/
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.28%
H: 0.04%
C: -1.1%
trodelvy chmp breast positive cancer
Anti-Ageing Drugs Market to Amass Notable Gains by 2029 Says Brandessence Market Research
Published: 2023-06-15 (Crawled : 14:00) - prnewswire.com
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: 0.38%
H: 0.07%
C: -0.63%
VRTX | News | $394.43 0.24% 0.24% 1.3M
|
Health Technology
|
| O: 0.95%
H: 1.62%
C: 1.42%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.65%
H: 0.0%
C: 0.0%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.42%
H: 0.93%
C: 0.92%
research market
Culture Biosciences Establishes Advisory Board of Biotech and Biopharma Executives to Guide the Corporate Strategy and Accelerate Growth
Published: 2023-06-01 (Crawled : 14:00) - biospace.com/
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.78%
H: 0.0%
C: -1.72%
biotech biopharma growth
Gilead and Kite Oncology to Showcase Advances Across the Pipeline Aiming to Address Unmet Needs in Cancer Care at ASCO 2023
Published: 2023-05-17 (Crawled : 14:00) - biospace.com/
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.22%
H: 1.12%
C: 0.85%
asco cancer pipeline care
George Washington University Hosting Webinar on HIV Testing and Screening Guidelines
Published: 2023-04-26 (Crawled : 14:00) - prnewswire.com
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -1.58%
H: 0.21%
C: -0.59%
guidelines hiv
Gilead Sciences: 4 Questions: Global Experts Convene To Identify Key Measures to Long-Term Success in HIV
Published: 2023-04-12 (Crawled : 14:00) - biospace.com/
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.52%
H: 0.33%
C: -0.98%
success global hiv
George Washington University to Host Webinar on Restoring Patient Trust Using a Health Justice Approach
Published: 2023-03-22 (Crawled : 14:00) - prnewswire.com
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.05%
H: 0.35%
C: -1.63%
health trust
Avidity Biosciences Announces Arthur A. Levin to Join Board of Directors and Transition to Distinguished Scientist and Strategic Leader
Published: 2023-02-23 (Crawled : 14:00) - biospace.com/
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.42%
H: 0.84%
C: -0.73%
RNA | $22.74 -1.3% -1.32% 1M
|
Health Technology
|
| O: 0.42%
H: 2.0%
C: -1.63%
Vir Biotechnology Appoints Sung Lee as Chief Financial Officer
Published: 2023-02-16 (Crawled : 14:00) - globenewswire.com
VIR | $7.96 0.0% 1.1M
|
Health Technology
|
| O: -1.65%
H: 0.3%
C: -2.7%
SGMO | $0.5143 6.02% 5.68% 1M
|
Health Technology
|
| O: 0.0%
H: 2.5%
C: -1.0%
MOR | News | $17.96 -0.5% -0.5% 180K
|
Health Technology
|
| O: -2.4%
H: 1.23%
C: -1.44%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.87%
H: 0.53%
C: -1.09%
financial
Gilead Demonstrates Transformative Potential Impact Of Antiviral Innovation at CROI 2023
Published: 2023-02-14 (Crawled : 14:00) - biospace.com/
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.11%
H: 0.02%
C: -2.18%
antiviral impact potential innovation
Gilead Awards $7.6 Million in Grants to Advance Health Equity in Breast Cancer
Published: 2023-02-01 (Crawled : 14:00) - biospace.com/
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.08%
H: 0.77%
C: -0.01%
awards breast health grants cancer
Arcellx and Kite Announce Strategic Collaboration to Co-Develop and Co-Commercialize Late-Stage Clinical CART-ddBCMA in Multiple Myeloma
Published: 2022-12-09 (Crawled : 14:00) - biospace.com/
ACLX | $51.67 -5.19% -5.48% 740K
|
|
| O: 20.66%
H: 9.21%
C: 7.11%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: -1.45%
collaboration
Kite Receives U.S. FDA Approval of Viral Vector Manufacturing Facility in Southern California to Produce Commercial Product
Published: 2022-10-03 (Crawled : 14:00) - biospace.com/
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 1.15%
H: 0.27%
C: -0.13%
fda california commercial approval
Red Biotechnology Market to Exceed US$ 609.6 Bn by 2031: TMR Study
Published: 2022-08-19 (Crawled : 14:00) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800
|
Health Technology
|
| O: 3.04%
H: 0.12%
C: -2.22%
TAK | News | $13.24 0.61% 0.0% 1.3M
|
Health Technology
|
| O: -2.05%
H: 0.29%
C: 0.07%
PFE A | $26.0 2.4% -0.15% 38M
|
Health Technology
|
| O: 0.54%
H: 1.24%
C: 0.63%
BMY | $48.93 1.3% 0.0% 10M
|
Health Technology
|
| O: 0.01%
H: 2.09%
C: 1.58%
REGN | $896.27 0.26% 0.25% 500K
|
Health Technology
|
| O: -0.62%
H: 0.57%
C: -0.42%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.25%
H: 1.19%
C: 0.49%
AZN | News | $68.56 0.29% 0.29% 4.7M
|
Health Technology
|
| O: 0.78%
H: 0.49%
C: 0.22%
study market
Gilead Sciences to Acquire MiroBio
Published: 2022-08-04 (Crawled : 14:00) - biospace.com/
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: -0.21%
H: 1.36%
C: -0.37%
sciences acquire
Global Cystic Fibrosis Market Report 2022-2030: CFTR Modulators Segment to Dominate the Market
Published: 2022-08-02 (Crawled : 14:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: -0.0%
H: 0.6%
C: 0.6%
NVSEF | $93.6375 6.88% 82K
|
Health Technology
|
| O: -2.62%
H: 0.0%
C: 0.0%
NVS | $94.36 1.93% 0.0% 2.3M
|
Health Technology
|
| O: -0.02%
H: 0.39%
C: -0.64%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.68%
H: 0.0%
C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.1%
H: 0.58%
C: -1.18%
ABBV | $166.41 1.06% 0.0% 5.5M
|
Health Technology
|
| O: -0.4%
H: 0.0%
C: 0.0%
VRTX | News | $394.43 0.24% 0.24% 1.3M
|
Health Technology
|
| O: 0.73%
H: 0.88%
C: -0.71%
GILD | $66.77 0.92% 0.91% 11M
|
Health Technology
|
| O: 0.23%
H: 0.97%
C: -0.33%
fibrosis global report market cystic fibrosis
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.